
Your Dose of Cannabis Education

Your Dose of Cannabis Education
Only have a minute but want to Learn something every day™? Sign up to receive Your Dose of Cannabis Education, bringing featured content from our course library right to your inbox each day.
Your Dose of Cannabis Education is based on data from the studies and reviews published in the current peer-reviewed medical journals. Whether you are a healthcare provider, patient, caregiver, an individual working in the healthcare sector, or just a curious person, you can benefit from Your Dose of Cannabis Education.
Wake up every morning and get your dose of unbiased evidence-based cannabis education!

"Cannabis exposure during pregnancy has been associated with low birth weight, small-for-gestational-age neonates, neonatal intensive care unit admission, and perinatal mortality. Neonates exposed to cannabinoids in utero also demonstrate altered arousal patterns, regulation, and excitability in the first month of life....[Some] studies suggest potential risk for postnatal neurocognitive and behavioral dysfunction, including attention deficit disorders, behavioral and short-term memory challenges, and intellectual disabilities. "

Yes. The oromucosal spray Sativex (nabiximols) is a cannabis extract that contains the principal cannabinoids delta-9-tetrahydrocannibinol (THC) and cannabidiol (CBD) in a 50:50 ratio, as well as specific minor cannabinoids and other non-cannabinoid components. Regulatory approval has been obtained in numerous countries outside the United States for the treatment of multiple sclerosis symptoms (nerve pain, spasticity, overactive bladder, and other symptoms). 
Yes, and in fact, "THC can be found in breast milk for up to 6 days after maternal consumption, [and ]it may be concentrated up to sevenfold compared with maternal plasma in chronic consumption....The relative infant dose, the amount absorbed, has been estimated to be 2.5% (range 0.4%–8.7%) of the maternal dose."
The specific musculoskeletal health conditions for which CBD is being evaluated include fibromyalgia, TMJ and myofascial pain, mild to moderate muscle pain, aromatase inhibitor-associated musculoskeletal symptoms (AIMSS), and joint arthritis. 
CBD reduces heart rate and blood pressure, and improves vasodilation in models of endothelial dysfunction. Also, CBD reduces inflammation and vascular hyperpermeability in diabetic models. 
Learn something every day™ in your
feed…
Our courses

CBD in Clinical Care V2

A Nationally Approved CME/CE Medical Marijuana Course V2

Cannabis Essentials CME/CE Bundle
New to TheAnswerPage? There’s lots we’d like to share with you and we don’t want you to miss a thing! Be sure to register today for “Your Dose of Cannabis Education” emails where you’ll gain valuable insights in small doses that fit your schedule and also be provided direct access to the archived daily content.

